India · Delayed Price · Currency is INR Neogen Chemicals Statistics
Total Valuation
NSE:NEOGEN has a market cap or net worth of INR 86.20 billion. The enterprise value is 98.16 billion.
| Market Cap | 86.20B |
| Enterprise Value | 98.16B |
Important Dates
The last earnings date was Monday, November 2, 2026.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Aug 13, 2026 |
Share Statistics
NSE:NEOGEN has 30.04 million shares outstanding. The number of shares has increased by 2.29% in one year.
| Current Share Class | 30.04M |
| Shares Outstanding | 30.04M |
| Shares Change (YoY) | +2.29% |
| Shares Change (QoQ) | +2.21% |
| Owned by Insiders (%) | 30.88% |
| Owned by Institutions (%) | 20.39% |
| Float | 13.64M |
Valuation Ratios
The trailing PE ratio is 191.31 and the forward PE ratio is 80.53. NSE:NEOGEN's PEG ratio is 1.17.
| PE Ratio | 191.31 |
| Forward PE | 80.53 |
| PS Ratio | 8.13 |
| PB Ratio | 5.22 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.17 |
Enterprise Valuation
| EV / Earnings | 233.29 |
| EV / Sales | 9.31 |
| EV / EBITDA | 55.67 |
| EV / EBIT | 68.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.04.
| Current Ratio | 1.35 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | 9.70 |
| Debt / FCF | n/a |
| Interest Coverage | 1.78 |
Financial Efficiency
Return on equity (ROE) is 3.40% and return on invested capital (ROIC) is 3.89%.
| Return on Equity (ROE) | 3.40% |
| Return on Assets (ROA) | 2.73% |
| Return on Invested Capital (ROIC) | 3.89% |
| Return on Capital Employed (ROCE) | 5.47% |
| Weighted Average Cost of Capital (WACC) | 7.87% |
| Revenue Per Employee | 14.89M |
| Profits Per Employee | 594,706 |
| Employee Count | 680 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.94 |
Taxes
In the past 12 months, NSE:NEOGEN has paid 171.90 million in taxes.
| Income Tax | 171.90M |
| Effective Tax Rate | 29.83% |
Stock Price Statistics
The stock price has increased by +129.13% in the last 52 weeks. The beta is 0.82, so NSE:NEOGEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +129.13% |
| 50-Day Moving Average | 2,369.40 |
| 200-Day Moving Average | 1,872.68 |
| Relative Strength Index (RSI) | 71.20 |
| Average Volume (20 Days) | 168,290 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEOGEN had revenue of INR 10.13 billion and earned 404.40 million in profits. Earnings per share was 15.00.
| Revenue | 10.13B |
| Gross Profit | 4.52B |
| Operating Income | 1.38B |
| Pretax Income | 576.30M |
| Net Income | 404.40M |
| EBITDA | 1.59B |
| EBIT | 1.38B |
| Earnings Per Share (EPS) | 15.00 |
Balance Sheet
The company has 4.44 billion in cash and 16.41 billion in debt, with a net cash position of -11.96 billion or -398.24 per share.
| Cash & Cash Equivalents | 4.44B |
| Total Debt | 16.41B |
| Net Cash | -11.96B |
| Net Cash Per Share | -398.24 |
| Equity (Book Value) | 15.78B |
| Book Value Per Share | 567.37 |
| Working Capital | 5.17B |
Cash Flow
In the last 12 months, operating cash flow was -1.12 billion and capital expenditures -8.05 billion, giving a free cash flow of -9.17 billion.
| Operating Cash Flow | -1.12B |
| Capital Expenditures | -8.05B |
| Depreciation & Amortization | 207.30M |
| Net Borrowing | 4.70B |
| Free Cash Flow | -9.17B |
| FCF Per Share | -305.14 |
Margins
Gross margin is 44.67%, with operating and profit margins of 13.62% and 3.99%.
| Gross Margin | 44.67% |
| Operating Margin | 13.62% |
| Pretax Margin | 5.69% |
| Profit Margin | 3.99% |
| EBITDA Margin | 15.67% |
| EBIT Margin | 13.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.30% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.29% |
| Shareholder Yield | -2.25% |
| Earnings Yield | 0.52% |
| FCF Yield | -11.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:NEOGEN is 2,431.18, which is -15.27% lower than the current price. The consensus rating is "Buy".
| Price Target | 2,431.18 |
| Price Target Difference | -15.27% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 50.50% |
| EPS Growth Forecast (3Y) | 85.35% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |